key: cord-1032598-ylmp8566
authors: Alicea Marrero, Minelys M.; Silio, Margarita; McQueen‐Amaker, Katie; Español, María; Velez, María; LeBlanc, Zachary
title: Posthematopoietic stem cell transplant COVID‐19 infection in a pediatric patient with IPEX syndrome
date: 2020-09-23
journal: Pediatr Blood Cancer
DOI: 10.1002/pbc.28578
sha: 9520742113a3b270c8b4dd450e32cdafe8bbbd97
doc_id: 1032598
cord_uid: ylmp8566

nan

To the Editor:

December 2019 marked the emergence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 8, 9 Several treatment approaches are under study. The antiviral remdesivir 10 has been shown to improve overall mortality in patients treated for COVID-19, 1 We trended inflammatory parameters daily (Table 1) , and based our treatment decision on a calculated H-score 5 Compared to their immunocompetent counterparts, immunocompromised patients with COVID-19 are at increased risk for secondary infections and progression to severe disease, as well as a different response to supportive care measures. 6 Studies have shown that SARS-CoV-2 acts mainly on T-lymphocytes; hence, a severely immunocompromised patient experiences a poorer outcome. A case report depicted two adult posttransplant patients with adequate graft function, on immunosuppressive therapy, that eventually died after developing multiorgan failure. 7 Our patient was treated aggressively, and we attributed the first decreasing trend in inflammatory markers (Table 1) 

Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2. J Pediatric Infect Dis Soc

COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment. U.S. Food and Drug Administration

Supportive treatment with tocilizumab for COVID-19: a systematic review

Effect of convalescent plasma therapy on viral shedding and survival in COVID-19 patients

COVID-19: consider cytokine storm syndromes and immunosuppression

Addressing the impact of the coronavirus disease (COVID-19) pandemic on hematopoietic cell transplantation: learning networks as a means for sharing best practices

COVID-19 in posttransplant patientsreport of 2 cases

Coronavirus Disease (COVID-19 Outbreak Situation. World Health Organization

COVID-19) Cases in the US

Treatment options for COVID-19: the reality and challenges

IL-6 in inflammation, immunity, and disease

Convalescent plasma transfusion for the treatment of COVID-19: systematic review